A Study to Evaluate the Differences in Pharmadynamics, Pharmacokinetics, and Safety Between Ciprofol and Propofol
Status:
Completed
Trial end date:
2020-09-18
Target enrollment:
Participant gender:
Summary
This is a single-center, open-label, randomized, two-stage, two-way crossover Phase I study
in healthy male subjects.The main objective is to evaluate the differences in pharmadynamics
(PD), pharmacokinetics (PK), and safety between ciprofol injectable emulsion and propofol
injectable emulsion at different doses in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Haisco Pharmaceutical Group Co., Ltd. Sichuan Haisco Pharmaceutical Group Co., Ltd.